Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,057.02 5.99 (0.57%) as of 4:30 Mon 7/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.66(B)
Last Volume: 383,195 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 54 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Goldberg Murray A SVP Administration & Asst Secr   •       –      –    2014-10-23 4 D $391.93 $13,016,779 D/D (33,212) 89,890     -
   Goldberg Murray A SVP Administration & Asst Secr   •       –      –    2014-10-23 4 OE $30.63 $1,837,800 D/D 60,000 123,102     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-10-16 4 AB $328.47 $40,955,057 I/I 122,127 22,657,685     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-10-15 4 AB $323.90 $51,970,265 I/I 158,368 22,535,558     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-10-01 4 GD $0.00 $0 I/I 591 155,777     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-09-23 4 GD $0.00 $0 I/I 7,820 0     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-09-16 4 B $347.78 $11,077,574 I/I 31,717 22,377,190 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-09-15 4 B $340.88 $27,802,187 I/I 80,824 22,345,473 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-09-12 4 B $345.07 $20,737,541 I/I 59,808 22,264,649 1.5     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-09-10 4 AS $350.07 $3,614,823 I/I (10,326) 92,947     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-09-08 4 AS $351.00 $702 I/I (2) 103,273     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-09-05 4 GD $0.00 $0 I/I 4 0     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2014-08-28 4 GA $0.00 $0 I/I 294 568,637     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2014-08-28 4 GD $0.00 $0 D/D 294 500,000     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2014-08-27 4 D $351.33 $1,906,317 D/D (5,426) 500,294     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2014-08-27 4 OE $314.31 $1,797,853 D/D 5,720 505,720     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2014-08-27 4 OE $21.25 $36,247 D/D 1,681 4,681     -
   Goldstein Joseph L Director   –       •      –    2014-08-27 4 S $350.31 $700,620 D/D (2,000) 4,000     -
   Tessier-Lavigne Marc Director   –       •      –    2014-08-27 4 S $352.20 $1,056,600 D/D (3,000) 1,187     -
   Tessier-Lavigne Marc Director   –       •      –    2014-08-27 4 OE $50.91 $152,730 D/D 3,000 4,187     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-08-26 4 D $351.62 $56,820,737 D/D (161,597) 390,852     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-08-26 4 OE $11.64 $3,537,501 D/D 303,909 552,449     -
   Tessier-Lavigne Marc Director   –       •      –    2014-08-26 4 D $351.62 $70,324 D/D (200) 1,187     -
   Tessier-Lavigne Marc Director   –       •      –    2014-08-26 4 OE $50.91 $70,612 D/D 1,387 1,387     -
   Aberman Michael S VP Strategy and Investor Relat   •       –      –    2014-08-22 4 OE $24.00 $72,000 D/D 3,000 18,600     -
  2430 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 54 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us